methanesulfonic acid has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ADHAULIA, HN; AGARWAL, LP; MEHRA, KS; SHURMA, CK | 1 |
| AMICI, R | 1 |
| Bae, SK; Choi, WK; Oh, E; Park, JB; Park, S; Seo, JH; Sung, YJ | 1 |
3 other study(ies) available for methanesulfonic acid and cardiovascular agents
| Article | Year |
|---|---|
Treatment of herpes zoster ophthalmicus with methanesulphonate of hydrogenated ergotamine.
Topics: Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Mesylates | 1953 |
[Clinical experimentation with 3-piperidino-1, 1-diphenylpropyl methanesulfonate].
Topics: Cardiovascular Agents; Mesylates; Muscle Relaxants, Central; Sulfonic Acids | 1962 |
Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate.
Topics: Administration, Oral; Animals; Area Under Curve; Benzenesulfonates; Biological Availability; Cardiovascular Agents; Chemistry, Pharmaceutical; Cilostazol; Drug Stability; Gastrointestinal Absorption; Male; Mesylates; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical; Tetrazoles; Wettability | 2015 |